Bank of America
MDNA

Bank of America’s Medicenna Therapeutics Corp. Common Shares MDNA Stock Holding History

Bank of America’s Portfolio MDNA Stock Details MDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,500
Closed -$1K – 8533
2022
Q3 		$1K Buy
+1,500
New +$1.69K ﹤0.01% 7726
2021
Q3 		– Sell
-19
Closed – – 8512
2021
Q2 		$0 Buy
+19
New +$70 ﹤0.01% 8225
2021
Q1 		– Sell
-23,619
Closed -$111K – 7900
2020
Q4 		$111K Buy
23,619
+23,519
+23,519% +$94.8K ﹤0.01% 5938
2020
Q3 		$0 Buy
+100
New +$402 ﹤0.01% 7279

Other funds holding MDNA

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.97B AUM 32.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Bank of America's MDNA Position: Q4 2022 in Review

Bank of America sold out of Medicenna Therapeutics Corp. Common Shares (MDNA) in Q4 2022, closing a stake of 1,500 shares — an estimated $1K sold.

Bank of America first reported a position in MDNA in Q3 2020 and held it in 4 quarters. The position peaked at $111K in Q4 2020. 27 funds tracked by Wall St. Rank hold MDNA as of Q4 2022.

  • Bank of America reported no remaining Medicenna Therapeutics Corp. Common Shares position as of Q4 2022 after selling out during the quarter.
  • Bank of America sold 1,500 Medicenna Therapeutics Corp. Common Shares shares in Q4 2022, an estimated $1K.
  • Bank of America first reported a position in Medicenna Therapeutics Corp. Common Shares in Q3 2020 and held it in 4 quarters.
  • Bank of America's Medicenna Therapeutics Corp. Common Shares position peaked at $111K in Q4 2020.
  • 27 funds tracked by Wall St. Rank held Medicenna Therapeutics Corp. Common Shares as of Q4 2022.

Based on Bank of America's 13F filing for Q4 2022, filed 10 Feb 2023.